Small RNAs have a large impact

References

• Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75:843 - 54; http://dx.doi.org/10.1016/0092-8674(93)90529-Y; PMID: 8252621
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136:215 - 33; http://dx.doi.org/10.1016/j.cell.2009.01.002; PMID: 19167326
   PubMed Web of Science ®Google Scholar
• Pasquinelli AE, Reinhart BJ, Slack F, Martindale MQ, Kuroda MI, Maller B, et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 2000; 408:86 - 9; http://dx.doi.org/10.1038/35040556; PMID: 11081512
   PubMed Web of Science ®Google Scholar
• Cobb BS, Nesterova TB, Thompson E, Hertweck A, O’Connor E, Godwin J, et al. T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer. J Exp Med 2005; 201:1367 - 73; http://dx.doi.org/10.1084/jem.20050572; PMID: 15867090
   PubMed Web of Science ®Google Scholar
• Harfe BD, McManus MT, Mansfield JH, Hornstein E, Tabin CJ. The RNaseIII enzyme Dicer is required for morphogenesis but not patterning of the vertebrate limb. Proc Natl Acad Sci U S A 2005; 102:10898 - 903; http://dx.doi.org/10.1073/pnas.0504834102; PMID: 16040801
   PubMed Web of Science ®Google Scholar
• Yang WJ, Yang DD, Na S, Sandusky GE, Zhang Q, Zhao G. Dicer is required for embryonic angiogenesis during mouse development. J Biol Chem 2005; 280:9330 - 5; http://dx.doi.org/10.1074/jbc.M413394200; PMID: 15613470
   PubMed Web of Science ®Google Scholar
• Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002; 99:15524 - 9; http://dx.doi.org/10.1073/pnas.242606799; PMID: 12434020
   PubMed Web of Science ®Google Scholar
• Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857 - 66; http://dx.doi.org/10.1038/nrc1997; PMID: 17060945
   PubMed Web of Science ®Google Scholar
• Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259 - 69; http://dx.doi.org/10.1038/nrc1840; PMID: 16557279
   PubMed Web of Science ®Google Scholar
• Mandel P, Metais P. Les acides necleiques du plasma sanguin chez l'Homme. C R Acad Sci Paris 1948; 142:241 - 3
   Google Scholar
• Ayala W, Moore LV, Hess EL. The purple color reaction given by diphenylamine reagent. I. With normal and rheumatic fever sera. J Clin Invest 1951; 30:781 - 5; http://dx.doi.org/10.1172/JCI102492; PMID: 14850558
   PubMed Web of Science ®Google Scholar
• Leon SA, Shapiro B, Sklaroff DM, Yaros MJ. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 1977; 37:646 - 50; PMID: 837366
   PubMed Web of Science ®Google Scholar
• Tong YK, Lo YM. Diagnostic developments involving cell-free (circulating) nucleic acids. Clin Chim Acta 2006; 363:187 - 96; http://dx.doi.org/10.1016/j.cccn.2005.05.048; PMID: 16126188
   PubMed Web of Science ®Google Scholar
• Stroun M, Anker P, Maurice P, Lyautey J, Lederrey C, Beljanski M. Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology 1989; 46:318 - 22; http://dx.doi.org/10.1159/000226740; PMID: 2779946
   PubMed Web of Science ®Google Scholar
• Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008; 18:997 - 1006; http://dx.doi.org/10.1038/cr.2008.282; PMID: 18766170
   PubMed Web of Science ®Google Scholar
• Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, et al. Serum microRNAs are promising novel biomarkers. PLoS One 2008; 3:e3148; http://dx.doi.org/10.1371/journal.pone.0003148; PMID: 18773077
   PubMed Web of Science ®Google Scholar
• Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008; 141:672 - 5; http://dx.doi.org/10.1111/j.1365-2141.2008.07077.x; PMID: 18318758
   PubMed Web of Science ®Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008; 105:10513 - 8; http://dx.doi.org/10.1073/pnas.0804549105; PMID: 18663219
   PubMed Web of Science ®Google Scholar
• Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, Hu Z, et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci U S A 2009; 106:4402 - 7; http://dx.doi.org/10.1073/pnas.0813371106; PMID: 19246379
   PubMed Web of Science ®Google Scholar
• Lodes MJ, Caraballo M, Suciu D, Munro S, Kumar A, Anderson B. Detection of cancer with serum miRNAs on an oligonucleotide microarray. PLoS One 2009; 4:e6229; http://dx.doi.org/10.1371/journal.pone.0006229; PMID: 19597549
   PubMed Web of Science ®Google Scholar
• Brase JC, Johannes M, Schlomm T, Fälth M, Haese A, Steuber T, et al. Circulating miRNAs are correlated with tumor progression in prostate cancer. Int J Cancer 2011; 128:608 - 16; http://dx.doi.org/10.1002/ijc.25376; PMID: 20473869
   PubMed Web of Science ®Google Scholar
• Tanaka M, Oikawa K, Takanashi M, Kudo M, Ohyashiki J, Ohyashiki K, et al. Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. PLoS One 2009; 4:e5532; http://dx.doi.org/10.1371/journal.pone.0005532; PMID: 19440243
   PubMed Web of Science ®Google Scholar
• Wang J, Chen J, Chang P, LeBlanc A, Li D, Abbruzzesse JL, et al. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. [Phila Pa] Cancer Prev Res (Phila) 2009; 2:807 - 13; http://dx.doi.org/10.1158/1940-6207.CAPR-09-0094; PMID: 19723895
   PubMed Web of Science ®Google Scholar
• Ho AS, Huang X, Cao H, Christman-Skieller C, Bennewith K, Le QT, et al. Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer. Transl Oncol 2010; 3:109 - 13; PMID: 20360935
   PubMed Web of Science ®Google Scholar
• Kong X, Du Y, Wang G, Gao J, Gong Y, Li L, et al. Detection of differentially expressed microRNAs in serum of pancreatic ductal adenocarcinoma patients: miR-196a could be a potential marker for poor prognosis. Dig Dis Sci 2011; 56:602 - 9; http://dx.doi.org/10.1007/s10620-010-1285-3; PMID: 20614181
   PubMed Web of Science ®Google Scholar
• Li A, Omura N, Hong SM, Vincent A, Walter K, Griffith M, et al. Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels. Cancer Res 2010; 70:5226 - 37; http://dx.doi.org/10.1158/0008-5472.CAN-09-4227; PMID: 20551052
   PubMed Web of Science ®Google Scholar
• Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM, Cohn DE. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 2009; 112:55 - 9; http://dx.doi.org/10.1016/j.ygyno.2008.08.036; PMID: 18954897
   PubMed Web of Science ®Google Scholar
• Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J, Kerin MJ. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 2010; 251:499 - 505; http://dx.doi.org/10.1097/SLA.0b013e3181cc939f; PMID: 20134314
   PubMed Web of Science ®Google Scholar
• Zhu W, Qin W, Atasoy U, Sauter ER. Circulating microRNAs in breast cancer and healthy subjects. BMC Res Notes 2009; 2:89; http://dx.doi.org/10.1186/1756-0500-2-89; PMID: 19454029
   PubMedGoogle Scholar
• Roth C, Rack B, Müller V, Janni W, Pantel K, Schwarzenbach H. Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Res 2010; 12:R90; http://dx.doi.org/10.1186/bcr2766; PMID: 21047409
   PubMed Web of Science ®Google Scholar
• Asaga S, Kuo C, Nguyen T, Terpenning M, Giuliano AE, Hoon DS. Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. Clin Chem 2011; 57:84 - 91; http://dx.doi.org/10.1373/clinchem.2010.151845; PMID: 21036945
   PubMed Web of Science ®Google Scholar
• Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 2009; 58:1375 - 81; http://dx.doi.org/10.1136/gut.2008.167817; PMID: 19201770
   PubMed Web of Science ®Google Scholar
• Huang Z, Huang D, Ni S, Peng Z, Sheng W, Du X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2010; 127:118 - 26; http://dx.doi.org/10.1002/ijc.25007; PMID: 19876917
   PubMed Web of Science ®Google Scholar
• Tsujiura M, Ichikawa D, Komatsu S, Shiozaki A, Takeshita H, Kosuga T, et al. Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer 2010; 102:1174 - 9; http://dx.doi.org/10.1038/sj.bjc.6605608; PMID: 20234369
   PubMed Web of Science ®Google Scholar
• Liu R, Zhang C, Hu Z, Li G, Wang C, Yang C, et al. A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur J Cancer 2011; 47:784 - 91; http://dx.doi.org/10.1016/j.ejca.2010.10.025; PMID: 21112772
   PubMed Web of Science ®Google Scholar
• Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, Wei WI. Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue. Clin Cancer Res 2008; 14:2588 - 92; http://dx.doi.org/10.1158/1078-0432.CCR-07-0666; PMID: 18451220
   PubMed Web of Science ®Google Scholar
• Lin SC, Liu CJ, Lin JA, Chiang WF, Hung PS, Chang KW. miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis. Oral Oncol 2010; 46:204 - 8; http://dx.doi.org/10.1016/j.oraloncology.2009.12.005; PMID: 20138800
   PubMed Web of Science ®Google Scholar
• Liu CJ, Kao SY, Tu HF, Tsai MM, Chang KW, Lin SC. Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer. Oral Dis 2010; 16:360 - 4; http://dx.doi.org/10.1111/j.1601-0825.2009.01646.x; PMID: 20233326
   PubMed Web of Science ®Google Scholar
• Zhang C, Wang C, Chen X, Yang C, Li K, Wang J, et al. Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma. Clin Chem 2010; 56:1871 - 9; http://dx.doi.org/10.1373/clinchem.2010.147553; PMID: 20943850
   PubMed Web of Science ®Google Scholar
• Komatsu S, Ichikawa D, Takeshita H, Tsujiura M, Morimura R, Nagata H, et al. Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma. Br J Cancer 2011; 105:104 - 11; http://dx.doi.org/10.1038/bjc.2011.198; PMID: 21673684
   PubMed Web of Science ®Google Scholar
• Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y, et al. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 2010; 28:1721 - 6; http://dx.doi.org/10.1200/JCO.2009.24.9342; PMID: 20194856
   PubMed Web of Science ®Google Scholar
• Foss KM, Sima C, Ugolini D, Neri M, Allen KE, Weiss GJ. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. J Thorac Oncol 2011; 6:482 - 8; http://dx.doi.org/10.1097/JTO.0b013e318208c785; PMID: 21258252
   PubMed Web of Science ®Google Scholar
• Liu XG, Zhu WY, Huang YY, Ma LN, Zhou SQ, Wang YK, et al. High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer. Med Oncol 2011; http://dx.doi.org/10.1007/s12032-011-9923-y; PMID: 21516486
   PubMed Web of Science ®Google Scholar
• Wei J, Gao W, Zhu CJ, Liu YQ, Mei Z, Cheng T, et al. Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer. Chin J Cancer 2011; 30:407 - 14; http://dx.doi.org/10.5732/cjc.010.10522; PMID: 21627863
   PubMedGoogle Scholar
• Kanemaru H, Fukushima S, Yamashita J, Honda N, Oyama R, Kakimoto A, et al. The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker. J Dermatol Sci 2011; 61:187 - 93; http://dx.doi.org/10.1016/j.jdermsci.2010.12.010; PMID: 21273047
   PubMed Web of Science ®Google Scholar
• Ji X, Takahashi R, Hiura Y, Hirokawa G, Fukushima Y, Iwai N. Plasma miR-208 as a biomarker of myocardial injury. Clin Chem 2009; 55:1944 - 9; http://dx.doi.org/10.1373/clinchem.2009.125310; PMID: 19696117
   PubMed Web of Science ®Google Scholar
• Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He J, et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 2010; 31:659 - 66; http://dx.doi.org/10.1093/eurheartj/ehq013; PMID: 20159880
   PubMed Web of Science ®Google Scholar
• Cheng Y, Tan N, Yang J, Liu X, Cao X, He P, et al. A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clin Sci (Lond) 2010; 119:87 - 95; http://dx.doi.org/10.1042/CS20090645; PMID: 20218970
   PubMed Web of Science ®Google Scholar
• Ai J, Zhang R, Li Y, Pu J, Lu Y, Jiao J, et al. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Commun 2010; 391:73 - 7; http://dx.doi.org/10.1016/j.bbrc.2009.11.005; PMID: 19896465
   PubMed Web of Science ®Google Scholar
• D’Alessandra Y, Devanna P, Limana F, Straino S, Di Carlo A, Brambilla PG, et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J 2010; 31:2765 - 73; http://dx.doi.org/10.1093/eurheartj/ehq167; PMID: 20534597
   PubMed Web of Science ®Google Scholar
• Tijsen AJ, Creemers EE, Moerland PD, de Windt LJ, van der Wal AC, Kok WE, et al. MiR423-5p as a circulating biomarker for heart failure. Circ Res 2010; 106:1035 - 9; http://dx.doi.org/10.1161/CIRCRESAHA.110.218297; PMID: 20185794
   PubMed Web of Science ®Google Scholar
• Laterza OF, Lim L, Garrett-Engele PW, Vlasakova K, Muniappa N, Tanaka WK, et al. Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury. Clin Chem 2009; 55:1977 - 83; http://dx.doi.org/10.1373/clinchem.2009.131797; PMID: 19745058
   PubMed Web of Science ®Google Scholar
• Vasilescu C, Rossi S, Shimizu M, Tudor S, Veronese A, Ferracin M, et al. MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS One 2009; 4:e7405; http://dx.doi.org/10.1371/journal.pone.0007405; PMID: 19823581
   PubMed Web of Science ®Google Scholar
• Wang JF, Yu ML, Yu G, Bian JJ, Deng XM, Wan XJ, et al. Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Biochem Biophys Res Commun 2010; 394:184 - 8; http://dx.doi.org/10.1016/j.bbrc.2010.02.145; PMID: 20188071
   PubMed Web of Science ®Google Scholar
• Rong H, Liu TB, Yang KJ, Yang HC, Wu DH, Liao CP, et al. MicroRNA-134 plasma levels before and after treatment for bipolar mania. J Psychiatr Res 2011; 45:92 - 5; http://dx.doi.org/10.1016/j.jpsychires.2010.04.028; PMID: 20546789
   PubMed Web of Science ®Google Scholar
• Starkey Lewis PJ, Dear J, Platt V, Simpson KJ, Craig DG, Antoine DJ, et al. Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology 2011; 54:1767 - 76; http://dx.doi.org/10.1002/hep.24538; PMID: 22045675
   PubMed Web of Science ®Google Scholar
• Wang G, Tam LS, Li EK, Kwan BC, Chow KM, Luk CC, et al. Serum and urinary free microRNA level in patients with systemic lupus erythematosus. Lupus 2011; 20:493 - 500; http://dx.doi.org/10.1177/0961203310389841; PMID: 21372198
   PubMed Web of Science ®Google Scholar
• Qi R, Weiland M, Gao XX, Zhou L, Mi QS. Identification of endogenous normalizers for serum miRNAs by microarray profiling: U6 snRNA is not a reliable normalizer. Hepatology 2011; http://dx.doi.org/10.1002/hep.25558; PMID: 22213067
   PubMed Web of Science ®Google Scholar
• Smalheiser NR. Exosomal transfer of proteins and RNAs at synapses in the nervous system. Biol Direct 2007; 2:35; http://dx.doi.org/10.1186/1745-6150-2-35; PMID: 18053135
   PubMed Web of Science ®Google Scholar
• Skog J, Würdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008; 10:1470 - 6; http://dx.doi.org/10.1038/ncb1800; PMID: 19011622
   PubMed Web of Science ®Google Scholar
• Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA. MicroRNAs in body fluids--the mix of hormones and biomarkers. Nat Rev Clin Oncol 2011; 8:467 - 77; http://dx.doi.org/10.1038/nrclinonc.2011.76; PMID: 21647195
   PubMed Web of Science ®Google Scholar